|
Delayed
NSE India S.E.
07:05:10 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 471.30 INR | -1.11% |
|
-0.58% | +51.84% |
| 09-20 | SMS Pharmaceuticals Limited(BSE:532815) added to S&P Global BMI Index | CI |
| 08-01 | SMS Pharmaceuticals Limited announces Annual dividend, payable on October 23, 2026 | CI |
Company Valuation: SMS Pharmaceuticals Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 10,518 | 7,915 | 4,931 | 15,089 | 18,863 | 35,105 |
| Change | - | -24.75% | -37.7% | 206.01% | 25.01% | 86.1% |
| Enterprise Value (EV) 1 | 12,660 | 10,082 | 7,398 | 17,536 | 21,556 | 38,296 |
| Change | - | -20.36% | -26.62% | 137.04% | 22.93% | 77.66% |
| P/E | 16.8x | 12.7x | -69.9x | 30.3x | 27.3x | 33.6x |
| PBR | 2.56x | 1.68x | 1.07x | 2.81x | 2.95x | 4.47x |
| PEG | - | -25.87x | 1x | -0x | 0.8x | 0.8x |
| Capitalization / Revenue | 1.86x | 1.52x | 0.94x | 2.13x | 2.41x | 3.95x |
| EV / Revenue | 2.24x | 1.94x | 1.42x | 2.47x | 2.75x | 4.31x |
| EV / EBITDA | 10.3x | 8.83x | 13.7x | 15x | 15.5x | 22.1x |
| EV / EBIT | 12.5x | 12.1x | 32.5x | 20.4x | 20.5x | 28.6x |
| EV / FCF | -12.4x | -44.8x | -23.4x | -70.3x | -31x | -41.1x |
| FCF Yield | -8.04% | -2.23% | -4.27% | -1.42% | -3.22% | -2.43% |
| Dividend per Share 2 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 |
| Rate of return | 0.24% | 0.32% | 0.52% | 0.22% | 0.19% | 0.11% |
| EPS 2 | 7.386 | 7.35 | -0.8339 | 5.886 | 7.799 | 11.15 |
| Distribution rate | 4.06% | 4.08% | -36% | 6.8% | 5.13% | 3.59% |
| Net sales 1 | 5,651 | 5,199 | 5,221 | 7,093 | 7,827 | 8,886 |
| EBITDA 1 | 1,227 | 1,142 | 541.8 | 1,169 | 1,387 | 1,735 |
| EBIT 1 | 1,014 | 830.7 | 227.3 | 860.1 | 1,049 | 1,338 |
| Net income 1 | 625.3 | 622.2 | -70.59 | 498.3 | 691.4 | 1,020 |
| Net Debt 1 | 2,142 | 2,167 | 2,467 | 2,447 | 2,693 | 3,191 |
| Reference price 2 | 124.25 | 93.50 | 58.25 | 178.25 | 212.78 | 374.85 |
| Nbr of stocks (in thousands) | 84,652 | 84,652 | 84,652 | 84,652 | 88,652 | 93,652 |
| Announcement Date | 9/8/21 | 9/7/22 | 9/7/23 | 9/6/24 | 9/6/25 | 9/4/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 458M | |
| 32.69x | 11.85x | 24.08x | 0.6% | 1,025B | |
| 28.77x | 6.4x | 17.91x | 2.06% | 623B | |
| 32.89x | 7.71x | 15.93x | 2.67% | 459B | |
| 104.62x | 5.85x | 24.82x | 2.37% | 355B | |
| 18.99x | 4.63x | 11.47x | 2.87% | 336B | |
| 20.13x | 5.23x | 12.95x | 3.06% | 270B | |
| 20.27x | 4.21x | 12x | 2.1% | 247B | |
| 25.72x | 6.72x | 11.97x | 2.48% | 220B | |
| -44.61x | 6.5x | 25.4x | 2.23% | 183B | |
| Average | 26.61x | 6.57x | 17.39x | 2.27% | 371.87B | |
| Weighted average by Cap. | 31.73x | 7.64x | 18.71x | 1.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SMSPHARMA Stock
- Valuation SMS Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
